Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Certain hormone treatments can improve acne and related conditions in women.

Hair loss requires customized treatments based on its various causes and types.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Reproductive gynecologists are the main referrers for male infertility evaluations in North America.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Genital rejuvenation is becoming popular for improving genital appearance and function in both men and women.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

In 2011, hair restoration was a specialized field in plastic surgery, using techniques like "Ultrarefined follicular unit hair transplantation" to minimize scarring and promote hair growth, with future treatments like stem cell therapy and hair cloning still being tested.